Alfred G. Merriweather, Chief Financial Officer at Adamas Pharmaceuticals Inc (ADMS), sold 857 shares at $7.99 ($7K) on 2019-03-20, disclosed to the SEC on 2019-03-21.
Open-market sale of $7k ADMS by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |